Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hiroshi Fuji

Showing results (1-10 of 44) with videos related to

Pageof 5
Sort By:
No Shinkei Geka. Neurological Surgery|December 9, 2025
[Progress in Radiotherapy for Pediatric Brain Tumors]Hiroshi Fuji
Gan to Kagaku Ryoho. Cancer & Chemotherapy|November 19, 2009
[Proton beam therapy at Shizuoka Cancer Center]Shigeyuki Murayama, Hiroshi Fuji
Radiological Physics and Technology|May 22, 2013
A revision of proton machine quality assurance for wobbled-proton-beam therapyYuki Kase, Haruo Yamashita, Masumi Numano, et al.
Journal of Radiation Research|November 5, 2013
Cost-effectiveness analysis of cochlear dose reduction by proton beam therapy for medulloblastoma in childhoodEmi Hirano, Hiroshi Fuji, Tsuyoshi Onoe, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 10, 2002
DNA alkylating agents alleviate silencing of class II transactivator gene expression in L1210 lymphoma cellsShawn P Murphy, Renae Holtz, Nicole Lewandowski, et al.
Immunology|September 11, 2009
The immunogenicity of L1210 lymphoma clones correlates with their ability to function as antigen-presenting cellsKelly A Cycon, James L Clements, Renae Holtz, et al.
Journal of Radiation Research|December 2, 2011
A treatment planning comparison of passive-scattering and intensity-modulated proton therapy for typical tumor sitesYuki Kase, Haruo Yamashita, Hiroshi Fuji, et al.
Skull Base : Official Journal of North American Skull Base Society ... [Et Al.]|March 28, 2012
Feasibility of proton beam therapy for chordoma and chondrosarcoma of the skull baseHiroshi Fuji, Yoko Nakasu, Yuji Ishida, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 14, 2005
Evaluation of anatomy-based dwell position and inverse optimization in high-dose-rate brachytherapy of prostate cancer: a dosimetric comparison to a conventional cylindrical dwell position, geometric optimization, and dose-point optimizationYasuo Yoshioka, Tetsuo Nishimura, Minoru Kamata, et al.
International Journal of Radiation Oncology, Biology, Physics|September 14, 2010
Multi-institutional Phase II study of proton beam therapy for organ-confined prostate cancer focusing on the incidence of late rectal toxicitiesKeiji Nihei, Takashi Ogino, Masakatsu Onozawa, et al.
Pageof 5

Showing results (1-10 of 44) with videos related to

Sort By:
Pageof 5
No Shinkei Geka. Neurological Surgery|December 9, 2025
[Progress in Radiotherapy for Pediatric Brain Tumors]Hiroshi Fuji
Gan to Kagaku Ryoho. Cancer & Chemotherapy|November 19, 2009
[Proton beam therapy at Shizuoka Cancer Center]Shigeyuki Murayama, Hiroshi Fuji
Radiological Physics and Technology|May 22, 2013
A revision of proton machine quality assurance for wobbled-proton-beam therapyYuki Kase, Haruo Yamashita, Masumi Numano, et al.
Journal of Radiation Research|November 5, 2013
Cost-effectiveness analysis of cochlear dose reduction by proton beam therapy for medulloblastoma in childhoodEmi Hirano, Hiroshi Fuji, Tsuyoshi Onoe, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 10, 2002
DNA alkylating agents alleviate silencing of class II transactivator gene expression in L1210 lymphoma cellsShawn P Murphy, Renae Holtz, Nicole Lewandowski, et al.
Immunology|September 11, 2009
The immunogenicity of L1210 lymphoma clones correlates with their ability to function as antigen-presenting cellsKelly A Cycon, James L Clements, Renae Holtz, et al.
Journal of Radiation Research|December 2, 2011
A treatment planning comparison of passive-scattering and intensity-modulated proton therapy for typical tumor sitesYuki Kase, Haruo Yamashita, Hiroshi Fuji, et al.
Skull Base : Official Journal of North American Skull Base Society ... [Et Al.]|March 28, 2012
Feasibility of proton beam therapy for chordoma and chondrosarcoma of the skull baseHiroshi Fuji, Yoko Nakasu, Yuji Ishida, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 14, 2005
Evaluation of anatomy-based dwell position and inverse optimization in high-dose-rate brachytherapy of prostate cancer: a dosimetric comparison to a conventional cylindrical dwell position, geometric optimization, and dose-point optimizationYasuo Yoshioka, Tetsuo Nishimura, Minoru Kamata, et al.
International Journal of Radiation Oncology, Biology, Physics|September 14, 2010
Multi-institutional Phase II study of proton beam therapy for organ-confined prostate cancer focusing on the incidence of late rectal toxicitiesKeiji Nihei, Takashi Ogino, Masakatsu Onozawa, et al.
Pageof 5